Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$137.62 - $174.96 $3.88 Million - $4.93 Million
-28,172 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $163,655 - $203,050
-1,240 Reduced 4.22%
28,172 $4.57 Million
Q4 2021

Jan 19, 2022

SELL
$107.43 - $135.93 $2.2 Million - $2.78 Million
-20,483 Reduced 41.05%
29,412 $3.98 Million
Q3 2021

Oct 05, 2021

BUY
$106.4 - $120.78 $10,852 - $12,319
102 Added 0.2%
49,895 $5.38 Million
Q2 2021

Jul 12, 2021

SELL
$105.21 - $117.21 $1.07 Million - $1.2 Million
-10,203 Reduced 17.01%
49,793 $5.61 Million
Q1 2021

Apr 22, 2021

SELL
$102.3 - $112.62 $558,353 - $614,679
-5,458 Reduced 8.34%
59,996 $6.49 Million
Q4 2020

Jan 25, 2021

BUY
$80.49 - $108.67 $418,708 - $565,301
5,202 Added 8.63%
65,454 $7.01 Million
Q3 2020

Oct 16, 2020

BUY
$85.91 - $100.83 $1.38 Million - $1.62 Million
16,104 Added 36.48%
60,252 $5.28 Million
Q2 2020

Jul 08, 2020

BUY
$73.37 - $98.18 $505,812 - $676,852
6,894 Added 18.51%
44,148 $4.33 Million
Q1 2020

Apr 07, 2020

BUY
$64.5 - $97.79 $851,206 - $1.29 Million
13,197 Added 54.86%
37,254 $2.84 Million
Q4 2019

Jan 07, 2020

SELL
$72.13 - $90.25 $66,864 - $83,661
-927 Reduced 3.71%
24,057 $2.13 Million
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $16,941 - $20,368
-269 Reduced 1.07%
24,984 $1.89 Million
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $11,891 - $15,200
-181 Reduced 0.71%
25,253 $1.84 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $13,653 - $16,069
177 Added 0.7%
25,434 $2.05 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $142,309 - $175,506
-1,828 Reduced 6.75%
25,257 $2.33 Million
Q3 2018

Nov 07, 2018

SELL
$88.91 - $98.84 $503,586 - $559,829
-5,664 Reduced 17.3%
27,085 $2.56 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $419,631 - $496,519
-4,674 Reduced 12.49%
32,749 $3.03 Million
Q1 2018

May 10, 2018

SELL
$92.01 - $123.21 $384,049 - $514,278
-4,174 Reduced 10.03%
37,423 $3.54 Million
Q4 2017

Feb 07, 2018

BUY
$89.56 - $98.21 $181,448 - $198,973
2,026 Added 5.12%
41,597 $4.39 Million
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $2.76 Million - $3.53 Million
39,571
39,571 $3.87 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ibm Retirement Fund Portfolio

Follow Ibm Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.